Those included various baseline characteristic including demographics (age, gender, race), comorbidities (e.g., liver diseases, chronic lower respiratory diseases, diabetic complications, obesity and neoplasm), medications (e.g., insulin, metformin, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), tacrolimus, cyclosporine, mycophenolate mofetil (MMF), and corticosteroids), as well as laboratory tests and physical findings (e.g., hemoglobin, glycated hemoglobin (HbA1c) levels, lipid profile, estimated glomerular filtration rate (eGFR) and systolic blood pressure (SBP))
Zhang Y, Zhao C, Zhang H, Liu R, Wang S, Pu Y, Yin L (2021) Integrating transcriptomics and behavior tests reveals how the C
Focal adhesion kinase (FAK) and paxillin are both involved in cell migration and adhesion dynamics during tissue repair
Prescribing decisions regarding concurrent use of Wegovy and corticosteroids should be individualised and based on a thorough assessment of the patient's overall health status, treatment goals, and the indication for corticosteroid therapy
The FDA will announce its next steps in approval by the end of 2025